相关实验视频

Updated: Jul 14, 2025

Isolation and Analysis of Aortic Arch and Root Lesions in an Atherosclerotic Mouse Model

Isolation and Analysis of Aortic Arch and Root Lesions in an Atherosclerotic Mouse Model

Published on: February 14, 2025

洛克斯-1受体:一个诊断工具和治疗点在异构造

Nikolaos Pyrpyris¹, Kyriakos Dimitriadis¹, Eirini Beneki¹

¹First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece.

Current problems in cardiology

|October 6, 2023

概括

拾尸体受体LOX-1 (乳素类氧化LDL受体-1) 通过调解氧化LDL吸收,在动脉样硬化发展中至关重要. 血清LOX-1显示为急性冠状动脉综合征的诊断生物标志物具有前途.

科学领域:

心血管研究研究心血管研究
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

低密度脂蛋白 (LDL) 和氧化LDL (oxLDL) 是动脉样硬化的主要驱动因素.
LOX-1 (莱克类氧化LDL受体-1) 是一种在内皮细胞表达的模式识别受体,它与oxLDL结合.
通过诸如oxLDL沉积和泡细胞形成等机制,LOX-1在动脉动脉生成中发挥着重要作用.

研究的目的:

审查LOX-1在动脉动脉生成中的作用.
探索LOX-1作为诊断生物标记物的潜力.
研究针对LOX-1的治疗策略.

主要方法:

在PubMed文献中搜索关于LOX-1和动脉样硬化的文章.
从已识别的手稿中查阅参考文献.
分析LOX-1在内皮细胞和巨细胞中的功能.

主要成果:

LOX-1调解了oxLDL的吸收,并有助于内皮功能障碍和泡细胞的形成.
血清LOX-1 (sLOX-1) 是诊断急性冠状动脉综合征的潜在生物标志物.
各种天然和合成分子表现出抗LOX-1的特性,表明治疗潜力.

结论:

LOX-1 是oxLDL诱导的动脉动脉生成的一个关键调解剂.
sLOX-1作为心血管事件的诊断生物标志物具有前景.
准LOX-1是一个潜在的治疗途径,尽管需要进一步的临床试验.

更多相关视频

Imaging and Analysis of Oil Red O-Stained Whole Aorta Lesions in an Aneurysm Hyperlipidemia Mouse Model

Imaging and Analysis of Oil Red O-Stained Whole Aorta Lesions in an Aneurysm Hyperlipidemia Mouse Model

Published on: May 2, 2022

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

相关概念视频

Atherosclerosis I: Introduction

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Receptor-mediated Endocytosis

Receptor-mediated Endocytosis